311 related articles for article (PubMed ID: 23669568)
1. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
Mock S; Leapman M; Stock RG; Hall SJ; Stone NN
J Urol; 2013 Nov; 190(5):1805-10. PubMed ID: 23669568
[TBL] [Abstract][Full Text] [Related]
2. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
Kollmeier MA; Stock RG; Cesaretti J; Stone NN
J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
[TBL] [Abstract][Full Text] [Related]
3. Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasible.
Brousil P; Hussain M; Lynch M; Laing RW; Langley SE
BJU Int; 2015 Apr; 115(4):580-6. PubMed ID: 24802744
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of continence following 532 nm laser prostatectomy for patients previously treated with radiation therapy or brachytherapy.
No D; Osterberg EC; Otto B; Naftali I; Choi B
Lasers Surg Med; 2013 Aug; 45(6):358-61. PubMed ID: 23813669
[TBL] [Abstract][Full Text] [Related]
5. The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Murray B; Allen Z; Lief JH; Galbreath RW
Brachytherapy; 2004; 3(1):22-9. PubMed ID: 15110310
[TBL] [Abstract][Full Text] [Related]
6. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
Mabjeesh NJ; Chen J; Stenger A; Matzkin H
Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy.
Abelson B; Reddy CA; Ciezki JP; Angermeier K; Ulchaker J; Klein EA; Wood HM
Urology; 2014 Feb; 83(2):422-7. PubMed ID: 24315301
[TBL] [Abstract][Full Text] [Related]
8. Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection.
Peddada AV; Jennings SB; Faricy PO; Walsh RA; White GA; Monroe AT
J Urol; 2007 Nov; 178(5):1963-7. PubMed ID: 17868718
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting for urinary incontinence after prostate brachytherapy.
McElveen TL; Waterman FM; Kim H; Dicker AP
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1395-404. PubMed ID: 15275725
[TBL] [Abstract][Full Text] [Related]
10. Urinary Incontinence Following Prostate Brachytherapy.
Leapman MS; Stone NN; Mock S; Stock RG; Hall SJ
Urology; 2016 Sep; 95():151-7. PubMed ID: 27210574
[TBL] [Abstract][Full Text] [Related]
11. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
Roth B; Studer UE; Fowler CJ; Kessler TM
J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
[TBL] [Abstract][Full Text] [Related]
12. Prediction of genitourinary tract morbidity after brachytherapy for prostate adenocarcinoma.
Wehle MJ; Lisson SW; Buskirk SJ; Broderick GA; Young PR; Igel TC
Mayo Clin Proc; 2004 Mar; 79(3):314-7. PubMed ID: 15008604
[TBL] [Abstract][Full Text] [Related]
13. Two-step transurethral surgery of the prostate and permanent implant brachytherapy for patients with lower urinary tract symptoms and low- to intermediate-risk prostate cancer.
Ivanowicz AN; Wakeman CM; Hubbard RT; DeVoe WB; Haake MR; Teigland CM
Brachytherapy; 2012; 11(6):483-8. PubMed ID: 21937283
[TBL] [Abstract][Full Text] [Related]
14. Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation.
Acher PL; Popert R; Morris SL; Potters L; Austin-Smith SL; Johnson UH; Nichol JE; Beaney RP
BJU Int; 2007 May; 99(5):1066-71. PubMed ID: 17233801
[TBL] [Abstract][Full Text] [Related]
15. Iodine-125 seed implantation and deferred transurethral resection of the prostate for patients with lower urinary tract symptoms and localized prostate cancer.
Liu R; Luo F; Zhang Z; Xu Y
Clin Genitourin Cancer; 2013 Sep; 11(3):251-5. PubMed ID: 23375828
[TBL] [Abstract][Full Text] [Related]
16. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
Sarosdy MF
Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
[TBL] [Abstract][Full Text] [Related]
17. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
Stone NN; Stock RG
Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
[TBL] [Abstract][Full Text] [Related]
18. Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?
Stone NN; Marshall DT; Stone JJ; Cesaretti JA; Stock RG
J Urol; 2010 Feb; 183(2):634-9. PubMed ID: 20018308
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized trial comparing conventional transurethral prostate resection with PlasmaKinetic vaporization of the prostate: physiological changes, early complications and long-term followup.
Hon NH; Brathwaite D; Hussain Z; Ghiblawi S; Brace H; Hayne D; Coppinger SW
J Urol; 2006 Jul; 176(1):205-9. PubMed ID: 16753403
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
